Customer Reviews

Best Practices in Biotechnology Business Development: Valuation, Licensing, Cash Flow, Pharmacoeconomics, Market Selection, Communication, and Intellectual Property

5 star:		(0)
4 star:		(0)
3 star:		(1)
2 star:		(0)
1 star:		(0)

 

 

This rather small book (186 pages) contains a collection of 11 articles written by 11 authors, covering biotechnology business development from various angles.

The quality of these articles is variable. Some articles are really good (still rather short) and some others are quite general. Also the focus is shattered around a bit with this "local expert" articles-approach.

So if interested in a rather basic overview dealing with biotech business development, go for it. On the other hand, if you expect a detailed in depth coverage I would encourage you to look elsewhere.

Overall the book cover price (US $67.95; £49.99) is rather expensive for the amount or quality of data covered.

Content:
1. Introduction - Yali Friedman
2. Top 5 Mistakes - Carlos N. Velez
3. Communicating with Investors and the Media - Fay Weston
4. Securing intellectual property from the inside out - John Avellanet
5. Aggressive intellectual property strategies - Gene Rzucidlo & Stefan Miller
6. Market based business development - Ryan Bethencourt
7. The ins and outs of in- and out-licensing - Gil Ben-Menachem
8. Free cash flow - the essential ingredient for growing a business - Gerald S. "Sandy" Graham
9. Biotechnology transfers and models facilitate access to biotechnology inventions - Oleksandr Skorokhod
10. Maximizing the strategy impact of health- and pharmaeconomics in biotechnology companies - Ulf Staginnus & Stephen Russell
11. Valuation of technologies through services - Ingrid Marchal-Gerez
12. How big is the world market for biopharmaceuticals - Ronald A. Rader